Amrutanjan Health Care (NSE:AMRUTANJAN) LT-Debt-to-Total-Asset : 0.00 (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Amrutanjan Health Care LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Amrutanjan Health Care's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.00.

Amrutanjan Health Care's long-term debt to total assets ratio increased from Mar. 2023 (0.00) to Mar. 2024 (0.00). It may suggest that Amrutanjan Health Care is progressively becoming more dependent on debt to grow their business.

Amrutanjan Health Care LT-Debt-to-Total-Asset Historical Data

The historical data trend for Amrutanjan Health Care's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amrutanjan Health Care LT-Debt-to-Total-Asset Chart

Amrutanjan Health Care Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.01

Amrutanjan Health Care Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	-	-	-	-

Amrutanjan Health Care LT-Debt-to-Total-Asset Calculation

Amrutanjan Health Care's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (A: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Mar. 2024 )	/	Total Assets (A: Mar. 2024 )
	=	13.968	/	3668.707
	=	0.00

Amrutanjan Health Care's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	13.968	/	3668.707
	=	0.00

Amrutanjan Health Care (NSE:AMRUTANJAN) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Amrutanjan Health Care LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Amrutanjan Health Care's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Amrutanjan Health Care (NSE:AMRUTANJAN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amrutanjan Health Care Ltd (NSE:AMRUTANJAN) » Definitions » LT-Debt-to-Total-Asset

Traded in Other Exchanges

590006:India

Address

No. 103 (Old No. 42-45), Luz Church Road, Mylapore, Chennai, TN, IND, 600 004

Website

https://www.amrutanjan.com

Amrutanjan Health Care Ltd manufactures Ayurvedic and allopathic products. The company operates through the following segments: OTC Products, Beverages, and Others. The majority of the revenue is generated from its OTC segment which is engaged in the manufacturing products of pain management, congestion management, and hygiene. Its beverage segment includes manufacturing fruit juices and oral rehydration drinks. Some of its products include Roll-on, Spray, Balm, Cough Syrup, Sanitary napkin, and inhaler. Geographically, it generates the majority of the revenue from India.

Amrutanjan Health Care (NSE:AMRUTANJAN) Headlines

No Headlines